title: Sex differences in the inflammatory mediator-induced sensitization of dural afferents.
abstract: Approximately 20% of the adult population suffers from migraine. This debilitating pain disorder is three times more prevalent in women than in men. To begin to evaluate the underlying mechanisms that may contribute to this sex difference, we tested the hypothesis that there is a sex difference in the inflammatory mediator (IM)-induced sensitization of dural afferents. Acutely dissociated retrogradely labeled dural afferents from adult Sprague-Dawley rats were examined with whole cell patch-clamp recordings. Baseline passive and active electrophysiological properties of dural afferents from both sexes were comparable. However, while IM-induced increases in the excitability of dural afferents from male and female rats were also comparable, the proportion of dural afferents from female rats sensitized by IM (~100%) was significantly greater than that of dural afferents from male rats (~50%). This appeared to be due to differences downstream of IM receptors, as tetrodotoxin-resistant sodium current was increased by IM in a majority of male dural afferents (13/14). These data indicate that there are both quantitative and qualitative differences in the IM-induced sensitization of dural afferents that may contribute to the sex difference in the manifestation of migraine.
authors.affiliation: The Center for Neuroscience at the University of Pittsburgh, PA 15213, USA.
authors.forename: N N
authors.initials: NN
authors.lastname: Scheff
authors.forename: M S
authors.initials: MS
authors.lastname: Gold
mesh_terms: D000200:Action Potentials; D000344:Afferent Pathways / Q000187:drug effects* / Q000503:physiopathology; D000818:Animals; D001808:Blood Vessels / Q000294:innervation; D001920:Bradykinin / Q000494:pharmacology*; D015232:Dinoprostone / Q000494:pharmacology*; D004195:Disease Models, Animal; D004388:Dura Mater / Q000098:blood supply*; D004558:Electric Stimulation; D005260:Female; D006632:Histamine / Q000494:pharmacology*; D018836:Inflammation Mediators / Q000494:pharmacology*; D015640:Ion Channel Gating / Q000187:drug effects; D008297:Male; D008881:Migraine Disorders; D058748:Pain Perception / Q000502:physiology*; D018408:Patch-Clamp Techniques; D051381:Rats; D017207:Rats, Sprague-Dawley; D044346:Receptor, Serotonin, 5-HT1D / Q000502:physiology; D011984:Sensory Receptor Cells / Q000187:drug effects* / Q000502:physiology; D012727:Sex Characteristics; D012964:Sodium / Q000378:metabolism; D013779:Tetrodotoxin / Q000494:pharmacology; D012668:Trigeminal Ganglion / Q000166:cytology
chemical_list: D018836:Inflammation Mediators; D044346:Receptor, Serotonin, 5-HT1D; D013779:Tetrodotoxin; D006632:Histamine; D012964:Sodium; D015232:Dinoprostone; D001920:Bradykinin